Table 1 Key baseline clinical characteristics of patients with stratification by stroke

Age (years)

49.00 (42.00–56.00)

49.00 (41.25–55.75)

52.00 (42.50–61.00)

0.094

Sex (male)

680 (87.18%)

643 (87.1%)

37 (88.1%)

0.855

BMI

22.70 (21.00-24.42)

22.70 (20.92–24.37)

22.50 (21.22–24.78)

0.856

ASA

< 0.001

II

71 (9.10%)

70 (9.5%)

1 (2.4%)

III

706 (90.51%)

668 (90.5%)

38 (90.5%)

IV

3 (0.38%)

0 (0.0%)

3 (7.1%)

Smoking

243 (31.15%)

225 (30.5%)

18 (42.9%)

0.092

Alcoholism

200 (25.64%)

184 (24.9%)

16 (38.1%)

0.057

Drug abuse

4 (0.51%)

4 (0.5%)

0 (0.0%)

0.632

Previous surgery

53 (6.79%)

49 (6.6%)

4 (9.5%)

0.47

Child Pugh score

10.00 (8.00–11.00)

10.00 (8.00–11.00)

10.00 (9.00–11.00)

0.035

SOFA

11.00 (9.00–13.00)

11.00 (9.00–13.00)

12.00 (10.25-14.00)

0.042

MELD

23.00 (22.00–34.00)

22.00 (22.00–34.00)

31.50 (23.25–39.50)

0.001

Comorbidities

Alcoholic liver disease

55 (7.05%)

48 (6.5%)

7 (16.7%)

0.012

Cirrhosis

642 (82.31%)

617 (83.6%)

25 (59.5%)

< 0.001

Portal hypertension

426 (54.62%)

411 (55.7%)

15 (35.7%)

0.011

Hypersplenism

416 (53.33%)

404 (54.7%)

12 (28.6%)

< 0.001

Fever

95 (12.18%)

85 (11.5%)

10 (23.8%)

0.018

Renal insufficiency

207 (26.54%)

191 (25.9%)

16 (38.1%)

0.081

Diabetes

109 (13.97%)

98 (13.3%)

11 (26.2%)

0.019

Hypertension

67 (8.59%)

63 (8.5%)

4 (9.5%)

0.824

HE

156 (20.00%)

140 (19.0%)

16 (38.1%)

0.003

Treatments

Mechanical ventilation

60 (7.69%)

53 (7.2%)

7 (16.7%)

0.025

Hemodialysis

230 (29.49%)

205 (27.8%)

25 (59.5%)

< 0.001

PE

170 (21.79%)

151 (20.5%)

19 (45.2%)

< 0.001

Laboratory tests

TYG index

8.23 (7.78–8.72)

8.21 (7.76–8.69)

8.68 (8.14–9.02)

< 0.001

Hemoglobin (g/L)

101.00 (83.00-122.00)

102.00 (83.00-122.57)

90.14 (75.25-106.25)

0.003

WBC (10⁹/L)

5.39 (3.58–8.76)

5.29 (3.55–8.55)

8.18 (3.96–11.82)

0.015

Platelet (10⁹/L)

72.52 (46.00-122.00)

73.00 (47.00-123.75)

58.50 (40.00–99.00)

0.063

FBG (mmol/L)

5.00 (4.22–6.43)

4.96 (4.20–6.27)

6.81 (4.75–10.04)

< 0.001

TC (mmol/L)

3.03 (2.08–3.93)

3.06 (2.10-4.00)

2.46 (1.90–3.41)

0.01

HDL (mmol/L)

0.47 (0.15–0.91)

0.48 (0.15–0.93)

0.34 (0.13–0.60)

0.02

FIB (g/L)

1.59 (1.05–2.65)

1.62 (1.07–2.67)

1.27 (0.82–1.89)

0.004

ALT (U/L)

54.90 (27.00-116.00)

54.00 (27.00-116.00)

83.85 (29.25-119.75)

0.005

IBIL (µmol/L)

38.83 (10.80-137.99)

36.40 (10.50-132.62)

111.60 (25.02–188.40)

0.026

SCr (µmol/L)

73.00 (60.00–92.00)

73.00 (60.00–91.00)

73.50 (59.50-148.75)

0.013

Intraoperative indicators

Night surgery

276 (35.38%)

251 (34.0%)

25 (59.5%)

< 0.001

Surgery duration

521.00 (470.00-580.00)

520.00 (470.00-580.00)

532.50 (486.00-622.25)

0.174

Donor type

0.005

DBD

471 (60.38%)

453 (61.4%)

18 (42.9%)

DCD

301 (38.59%)

279 (37.8%)

22 (52.4%)

DBCD

8 (1.03%)

6 (0.8%)

2 (4.8%)

Massive transfusion

231 (29.62%)

210 (28.5%)

21 (50.0%)

0.003

Massive blood losing

37 (4.74%)

30 (4.1%)

7 (16.7%)

< 0.001

Urinary oliguria

32 (4.10%)

25 (3.4%)

7 (16.7%)

< 0.001

Cardiac arrest

16 (2.036%)

13 (1.762%)

3 (7.143%)

0.017